Literature DB >> 21991704

Pain during rigid cystoscopy: a prospective randomized controlled study comparing the benefit of cooled and room temperature lignocaine gel.

K K Bhomi1, S Rizal, M Pradhan, A Rijal, C L Bhattachan.   

Abstract

Lignocaine gel is an established topical anesthetic agent for cystoscopy in awake patients. We performed a prospective randomized study to evaluate whether cooling the lignocaine gel to 4 degrees C decreases the pain perception during cystoscopy in male patients. Sixty consecutive male patients undergoing rigid cystoscopy were randomized into two groups. Group I received 15 ml of 2% lignocaine hydrochloride gel at 4 degrees C and group II received the same agent at room temperature (20 degrees C). Cystoscopy was performed and pain perceived during the procedure was assessed by independent evaluator using Wong-Baker FACES pain scale rating chart. The mean pain score in group I was lower (4.32 +/- 1.70) than that in group II (5.28 +/- 1.99), but this difference was statistically not significant (p=0.191). However significantly greater percentage (84% Vs 52%) of patients with cooled lignocaine wished to have same anesthetic in future for similar procedure (p=0.032). In conclusion, cooling the lignocaine gel to 4 degrees C does not decrease the pain perception during rigid cystoscopy in male patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21991704

Source DB:  PubMed          Journal:  Nepal Med Coll J


  2 in total

1.  2% Lidocaine gel or plain lubricating gel: Which one should be used in male flexible cystoscopy?

Authors:  Ali Akkoç; Mahir Kartalmış; Cemil Aydın; Ramazan Topaktaş; Selçuk Altın; Aykut Aykaç
Journal:  Turk J Urol       Date:  2016-06

2.  Anaesthesia of the posterior urethra and pain reduction during cystoscopy - a randomized controlled trial.

Authors:  Sławomir Poletajew; Sylwia Bender; Paweł Pudełko; Marcin Łykowski; Tomasz Piecha; Bartosz Sutkowski; Piotr Radziszewski
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2017-03-13       Impact factor: 1.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.